Chronic cocaine administration increases CNS tyrosine hydroxylase enzyme activity and mRNA levels and tryptophan hydroxylase enzyme activity levels - PubMed (original) (raw)
Chronic cocaine administration increases CNS tyrosine hydroxylase enzyme activity and mRNA levels and tryptophan hydroxylase enzyme activity levels
S L Vrana et al. J Neurochem. 1993 Dec.
Abstract
Cocaine is an inhibitor of dopamine and serotonin reuptake by synaptic terminals and has potent reinforcing effects that lead to its abuse. Tyrosine hydroxylase (TH) and tryptophan hydroxylase (TPH) catalyze the rate-limiting steps in dopamine and serotonin biosynthesis, respectively, and are the subject of dynamic regulatory mechanisms that could be sensitive to the actions of cocaine. This study assessed the effects of chronic cocaine on brain TH and TPH activities. Cocaine was administered (0.33 mg/infusion, i.v.) to rats for 7 days every 8 min for 6 h per day. This administration schedule is similar to patterns of self-administration by rats when given ad libitum access to this dose. This chronic, response-independent administration increased TH enzyme activity in the substantia nigra (30%) and ventral tegmental area (43%). Moreover, TH mRNA levels were also increased (45 and 50%, respectively). In contrast to the enzymatic and molecular biological changes in the cell bodies, TH activity was unchanged in the terminal fields (corpus striatum and nucleus accumbens). Similarly, TPH activity was increased by 50% in the raphe nucleus (serotonergic cell bodies). In summary, the chronic response-independent administration of cocaine produces increases in the expression of TH mRNA and activity in both the cell bodies of motor (nigrostriatal) and reinforcement (mesolimbic) dopamine pathways. These increases are not manifested in the terminal fields of these pathways.
Similar articles
- Effect of methamphetamine self-administration on tyrosine hydroxylase and dopamine transporter levels in mesolimbic and nigrostriatal dopamine pathways of the rat.
Shepard JD, Chuang DT, Shaham Y, Morales M. Shepard JD, et al. Psychopharmacology (Berl). 2006 May;185(4):505-13. doi: 10.1007/s00213-006-0316-4. Epub 2006 Mar 23. Psychopharmacology (Berl). 2006. PMID: 16555063 - Tyrosine hydroxylase mRNA and protein are down-regulated by chronic clozapine in both the mesocorticolimbic and the nigrostriatal systems.
Tejedor-Real P, Faucon Biguet N, Dumas S, Mallet J. Tejedor-Real P, et al. J Neurosci Res. 2003 Apr 1;72(1):105-15. doi: 10.1002/jnr.10555. J Neurosci Res. 2003. PMID: 12645084 - Brain 5-hydroxytryptamine metabolism: adaptive changes after long-term administration of psychotropic drugs.
Rastogi RB, Singhal RL. Rastogi RB, et al. Gen Pharmacol. 1978;9(5):307-14. doi: 10.1016/0306-3623(78)90066-6. Gen Pharmacol. 1978. PMID: 359406 Review. No abstract available. - Regulation of tryptophan and tyrosine hydroxylase.
Lovenberg W, Victor SJ. Lovenberg W, et al. Life Sci. 1974 Jun 16;14(12):2337-53. doi: 10.1016/0024-3205(74)90130-1. Life Sci. 1974. PMID: 4157279 Review. No abstract available.
Cited by
- MHC class I in dopaminergic neurons suppresses relapse to reward seeking.
Murakami G, Edamura M, Furukawa T, Kawasaki H, Kosugi I, Fukuda A, Iwashita T, Nakahara D. Murakami G, et al. Sci Adv. 2018 Mar 14;4(3):eaap7388. doi: 10.1126/sciadv.aap7388. eCollection 2018 Mar. Sci Adv. 2018. PMID: 29546241 Free PMC article. - Identification of tyrosine hydroxylase as a physiological substrate for Cdk5.
Kansy JW, Daubner SC, Nishi A, Sotogaku N, Lloyd MD, Nguyen C, Lu L, Haycock JW, Hope BT, Fitzpatrick PF, Bibb JA. Kansy JW, et al. J Neurochem. 2004 Oct;91(2):374-84. doi: 10.1111/j.1471-4159.2004.02723.x. J Neurochem. 2004. PMID: 15447670 Free PMC article. - Contributions of serotonin in addiction vulnerability.
Kirby LG, Zeeb FD, Winstanley CA. Kirby LG, et al. Neuropharmacology. 2011 Sep;61(3):421-32. doi: 10.1016/j.neuropharm.2011.03.022. Epub 2011 Apr 3. Neuropharmacology. 2011. PMID: 21466815 Free PMC article. Review. - Putative presynaptic dopamine dysregulation in schizophrenia is supported by molecular evidence from post-mortem human midbrain.
Purves-Tyson TD, Owens SJ, Rothmond DA, Halliday GM, Double KL, Stevens J, McCrossin T, Shannon Weickert C. Purves-Tyson TD, et al. Transl Psychiatry. 2017 Jan 17;7(1):e1003. doi: 10.1038/tp.2016.257. Transl Psychiatry. 2017. PMID: 28094812 Free PMC article. - Attenuation of cocaine and methamphetamine neurotoxicity by coenzyme Q10.
Klongpanichapak S, Govitrapong P, Sharma SK, Ebadi M. Klongpanichapak S, et al. Neurochem Res. 2006 Mar;31(3):303-11. doi: 10.1007/s11064-005-9025-3. Neurochem Res. 2006. PMID: 16733807
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources